Lineage Cell Therapeutics (United States)
Lineage Cell Therapeutics, Inc. is a clinical-stage biotechnology company developing novel cell therapies for unmet medical needs. Lineage’s programs are based on its robust proprietary cell-based therapy platform and associated in-house development and manufacturing capabilities. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Lineage Cell Therapeutics (United States), United States, covering academic research published from 2000 to 2024. Read More.
Open Access Percentage
61%
Total
Publications
154
Total Open
Publications
94
Total
Citations
6.7K
Open Access
Percentage
61%
Total
Publications
154
Total Open
Publications
94
Total
Citations
6.7K
Breakdown
Publisher Open
14%
Both
30%
Other Platform Open
17%
Closed
39%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 26%
18
Hybrid 46%
31
No Guarantees 28%
19
Other Platform Open
Domain 86%
63
Institution 18%
13
Public 16%
12
Other Internet 11%
8
Preprint 5%
4
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 61 |
Europe PMC | Domain | 49 |
Semantic Scholar | Public | 12 |
University of Southern Denmark - University of Southern Denmark Research Portal | Institution | 6 |
DOI | Other Internet | 4 |
University of Oslo - Duo Research Archive | Institution | 3 |
University of California - eScholarship University of California | Institution | 3 |
U.S. Department of Energy Office of Scientific and Technical Information - OSTI OAI | Institution | 3 |
bioRxiv | Preprint | 3 |
University of Leeds, The University of Sheffield, University of York - White Rose Research Online | Institution | 2 |